STOCK TITAN
  1. Home
  2. Sec-filings
  3. CRSP
  4. [Form 4] CRISPR Therapeutics AG Insider Trading Activity

[Form 4] CRISPR Therapeutics AG Insider Trading Activity

Filing Impact
(High)
Filing Sentiment
(Very Positive)
Form Type
4

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock CRSP logo
Crispr Therapeut

NASDAQ:CRSP

CRSP Rankings

#1385 Ranked by Market Cap
N/A Ranked by Dividends

CRSP Latest News

Sep 2, 2025
CRISPR Therapeutics to Participate in Upcoming Investor Conferences
Aug 4, 2025
CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results
Jun 30, 2025
CRISPR Therapeutics Named to TIME’s Most Influential Companies List of 2025
Jun 26, 2025
CRISPR Therapeutics Reports Positive Additional Phase 1 Data for CTX310™ Targeting ANGPTL3 and Provides Update on In Vivo Cardiovascular Pipeline
May 29, 2025
CRISPR Therapeutics to Participate in Upcoming Investor Conferences

CRSP Latest SEC Filings

Aug 19, 2025
[Form 4] CRISPR Therapeutics AG Insider Trading Activity
Aug 8, 2025
[Form 4] CRISPR Therapeutics AG Insider Trading Activity
Aug 4, 2025
[10-Q] CRISPR Therapeutics AG Quarterly Earnings Report
Aug 4, 2025
[8-K] CRISPR Therapeutics AG Reports Material Event
Jun 26, 2025
[8-K] CRISPR Therapeutics AG Reports Material Event

CRSP Stock Data

4.80B
89.46M
1.64%
80.92%
26.53%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
Switzerland
ZUG